carbapenems has been researched along with Blood Poisoning in 170 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.59) | 18.7374 |
| 1990's | 6 (3.53) | 18.2507 |
| 2000's | 12 (7.06) | 29.6817 |
| 2010's | 59 (34.71) | 24.3611 |
| 2020's | 92 (54.12) | 2.80 |
| Authors | Studies |
|---|---|
| Alp, E; Dinç, G; Doğanay, M; Eryılmaz-Eren, E; Kontaş, O | 1 |
| Brunkhorst, FM; Hagel, S; Löffler, B; Pletz, MW; Rißner, F; Scherag, A; Schmitz, RPH; Schöneweck, F; Weis, S | 1 |
| Bassetti, M; Castaldo, N; Giacobbe, DR; Vena, A | 1 |
| Al Sanabani, SS; Costa, SF; Guimarães, T; Leite, G; Levin, AS; Martins, RCR; Ramos, JF; Rizek, C; Rocha, V; Rossi, F | 1 |
| Costa, SF; Deo, B; Farrel Côrtes, M; Perdigão, L; Rizek, C; Rodrigues Pires de Campos, L; Santos, S | 1 |
| Cabebe, AE; Eriguchi, Y; Hawes, C; Ouellette, AJ; Pike, K; Schaal, JB; Selsted, ME; Tran, DQ; Tran, PA; Trinh, K | 1 |
| Chen, Y; Ji, J; Liu, Z; Luo, Q; Xiao, Y; Xiong, L; Ying, C; Yu, W | 1 |
| Cai, X; Hu, YB; Jin, MM; Li, RY; Liu, C; Liu, L; Wan, L; Wu, XJ; Zhang, HY | 1 |
| Hsueh, PR; Huang, YT; Ko, WC; Kuo, YW; Lee, NY; Liao, CH; Teng, LJ; Tien, N | 1 |
| Akova, M; Aslan, AT; Bıçakcıgil, A; Dağ, O; Gürsoy, NC; Güven, GS; Hazırolan, G; Kırbaş, E; Liste, Ü; Otlu, B; Sancak, B; Tanrıverdi, ES; Tozluyurt, A; Yılmaz, YA | 1 |
| Cai, W; Chen, J; Ye, J; Ye, Y; Ying, P | 1 |
| Akalin, H; Akova, M; Arabacı, Ç; Aslan, AT; Aydın, M; Azap, A; Azap, Ö; Bakır, VO; Balkan, İİ; Can, F; Chatfield, MD; Çınar, G; Demir, SK; Demirkaya, H; Doğan, Ö; Dolapçı, İ; Ergönül, Ö; Falconer, C; Forde, B; Gönen, M; Hazırolan, G; Isler, B; Kapmaz, M; Keske, Ş; Menekşe, Ş; Özer, B; Paterson, DL; Saltoğlu, N; Şimşek, F; Tigen, ET; Tülek, N; Vatansever, C; Yağcı, S | 1 |
| Akcan, RE; Akyol, M; Barçın, E; Can, F; Demirlenk, YM; Ergönül, Ö; Gönen, M; Gücer, LS; Kalay, Z; Tanrıöver, C; Uçku, D | 1 |
| Barnini, S; Della Sala, L; Falcone, M; Farcomeni, A; Leonildi, A; Menichetti, F; Tiseo, G; Vecchione, A | 1 |
| Chen, Y; Du, B; Huang, HB; Peng, JM; Weng, L | 1 |
| Azuma, M; Baba, H; Chikumi, H; Fujikura, Y; Fujita, J; Furuhashi, K; Hamada, Y; Igari, H; Iguchi, M; Ishiguro, N; Iwasaki, H; Kakeya, H; Kanai, S; Kasahara, K; Kato, H; Kawamura, H; Kusama, F; Matsumoto, A; Morioka, H; Nagamori, T; Nagao, M; Nakanishi, M; Nakata, H; Ohge, H; Oka, K; Saito, N; Shimono, N; Takahashi, S; Takajo, I; Tauchi, H; Tetsuka, N; Tokuda, K; Yagi, T | 1 |
| Akarca, FK; Akdağ, D; Akyol, D; Arda, B; Avşar, CB; Başkol, D; Bozbıyık, O; Bozkurt, D; Çankayalı, İ; Çilli, F; Demir, M; Demirağ, K; Erdem, HA; Kahraman, Ü; Kenanoğlu, B; Memetali, SC; Mert, M; Önal, U; Özgiray, E; Pullukçu, H; Quliyeva, G; Şanlıdağ, G; Sipahi, H; Sipahi, OR; Taşbakan, MI; Ulusoy, S; Uyan-Önal, A; Uyar, M; Yamazhan, T | 1 |
| Akhmedov, M; Drokov, M; Fedorova, A; Klyasova, G; Kuzmina, L; Parovichnikova, E; Vasilyeva, V | 1 |
| Braun-Feldweg, J; Germer, CT; Lock, JF; Meyer-Sautter, P; Rüsch, J; Surat, G | 1 |
| Aguado, JM; Fernández-Ruiz, M; Gutiérrez-Gutiérrez, B; Martínez-Martínez, L; Pascual, Á; Pérez-Nadales, E; Rodríguez-Baño, J; Torre-Cisneros, J | 1 |
| Chen, Y; Cui, Y; Deng, J; Guo, P; Huang, B; Kong, Y; Liao, K; Liu, P; Peng, Y; Wu, Z | 1 |
| Alby, K; Ammazzalorso, A; Anesi, JA; Bilker, WB; Blumberg, EA; Han, JH; Lautenbach, E; Omorogbe, J; Pineles, L; Tamma, PD; Thom, KA; Tolomeo, P; Werzen, A | 1 |
| Aseffa, A; Asrat, D; Hasan, B; Legese, MH; Mekasha, A; Mihret, A; Swedberg, G | 1 |
| Jia, P; Jia, X; Kang, M; Li, R; Li, X; Liu, X; Xu, Y; Yang, Q; Yu, W; Zhu, Y | 1 |
| Barros, A; Bergo, P; Gonçalves, L; Guasso, I; Pedroso, S; Ramos, F; Rigatto, MH; Zavascki, AP | 1 |
| Akalin, H; Ener, B; Özakin, C; Payaslioğlu, M; Ülkü Tüzemen, N | 1 |
| De Filippis, A; Della Rocca, MT; Finamore, E; Foglia, F; Galdiero, M; Manfredini, M; Melardo, C; Montella, F; Nastri, BM | 1 |
| Chen, J; Chen, Y; Guo, J; Jia, R; Jin, M; Jin, Y; Liu, F; Liu, J; Liu, X; Qi, L; Qin, S; Tang, Y; Wang, C; Wang, Y; Yang, X; Zhang, N; Zhang, X | 1 |
| Bai, Y; Fan, X; Fu, L; Tian, C; Wang, S; Xing, M; Zhao, Y | 1 |
| Kim, M; Kim, Y; Krishnan, M; Lee, H; Yoon, YK | 1 |
| Dissaneevate, S; Janjindamai, W; Maneenil, G; Phatigomet, M; Thatrimontrichai, A | 1 |
| Gagliotti, C; Högberg, LD; Kinross, P; Merk, H; Monnet, DL; Plachouras, D | 1 |
| Beiwen, W; Erzhen, C; Qin, Z; Yi, D; Yin, Z; Zhenzhu, M | 1 |
| Chen, L; Cheng, S; Chu, TY; Clancy, CJ; Driscoll, E; Fleres, G; Hao, B; Kreiswirth, BN; Liu, G; Newbrough, A; Nguyen, MH; Shields, RK; Squires, KM | 1 |
| de Jonge, NA; de la Court, JR; Heijmans, J; Huynh, J; Schade, RP; Sieswerda, E; Sigaloff, KCE; van Dijk, K | 1 |
| Chen, J; Cui, Y; Huang, X; Ma, H; Ma, S; Niu, R; Pan, P; Peng, W; Rao, M; Su, L; Yang, H; Zhang, P; Zhu, F | 1 |
| Cai, Y; Wang, J; Wang, Y; Xiao, Q; Xu, J; Zhang, H; Zhu, M | 1 |
| Bawankule, S; Joshi, P; Nabar, N; Singhal, T | 1 |
| Barchia, I; Karmila, A; Ramandati, A; Zhang, L | 1 |
| Bilen, NM; Cilli, F; Güner Özenen, G; Kurugöl, Z; Ozdemir Karadas, N; Ozek, G; Sahbudak Bal, Z; Yazici, P; Yildirim Arslan, S | 1 |
| Albanese, A; Buscemi, C; Cacopardo, B; Carbonara, S; Carretta, A; Cascio, A; Ceccarelli, G; Coppola, N; Corbo, L; Corrao, S; d'Errico, ML; Dalfino, L; De Stefano, G; Del Vecchio, RF; Di Caprio, G; Falcone, M; Farcomeni, A; Foti, G; Franco, A; Gentile, I; Gioè, C; Iacobello, C; Macera, M; Maraolo, AE; Mariani, MF; Marino, A; Medaglia, AA; Menichetti, F; Morana, U; Mularoni, A; Pieralli, F; Raponi, G; Santantonio, T; Scotto, R; Sgroi, C; Talamanca, S; Tiseo, G; Venditti, M | 1 |
| Annecchiarico, A; Bucci, L; Della Rocca, MT; Durante, A; Greco, R; Matano, A; Panetta, V | 1 |
| Kong, W; Li, S; Shu, Y; Song, B; Yang, K; Yang, X | 1 |
| Das, S; Mallick, A; Mondal, KC; Roy, A; Sarkar, S | 1 |
| Chen, X; Ren, Y; Xu, J; Zhao, L; Zhu, Q | 1 |
| Fujimi, S; Ogura, H; Tanaka, Y; Umemura, Y; Yamakawa, K; Yoshimura, J | 1 |
| Leng, T; Li, XL; Liao, QF; Shu, L; Wu, CY; Xiao, YL; Xie, Y; Zhang, WL | 1 |
| Akbaş, T; Akdoğan, Ö; Akova, M; Aksoy, F; Akyol, A; Aslan, AT; Barbier, F; Batirel, A; Bayindir, Y; Bilir, Y; Buetti, N; Çeşme, U; Çolak, O; Dağ, O; Dindar, EK; Eroğlu, A; Erol, Ç; Ersöz, G; Ferlicolak, L; Gürbüz, Y; Guzeldağ, S; Kalem, AK; Karaali, R; Köylü, B; Öztürk, B; Ruckly, S; Selçuk, M; Staiquly, Q; Sungurtekin, H; Tabah, A; Timsit, JF; Timuroğlu, A; Tunay, B; Yilmaz, M | 1 |
| Adhisivam, B; Agarwal, R; Ahmed, NU; Balasegaram, M; Ballot, D; Bekker, A; Berezin, EN; Berkley, JA; Bielicki, JA; Bilardi, D; Boonkasidecha, S; Carvalheiro, CG; Chami, N; Chaurasia, S; Chiurchiu, S; Colas, VRF; Cook, A; Cousens, S; Cressey, TR; de Assis, ACD; Dien, TM; Ding, Y; Dong, H; Dramowski, A; Ds, M; Dudeja, A; Dung, NT; Ellis, S; Feng, J; Glupczynski, Y; Goel, S; Goossens, H; Hao, DTH; Heath, PT; Huertas, TM; Islam, MS; Jarovsky, D; Khan, MI; Khavessian, N; Khorana, M; Kontou, A; Kostyanev, T; Laoyookhon, P; Larsson, M; Lochindarat, S; Luca, M; Malhotra-Kumar, S; Mondal, N; Mundhra, N; Musoke, P; Mussi-Pinhata, MM; Nakwa, F; Nanavati, R; Nangia, S; Nankunda, J; Nardone, A; Nyaoke, B; Obiero, CW; Owor, M; Ping, W; Plakkal, N; Preedisripipat, K; Qazi, S; Qi, L; Ramdin, T; Riddell, A; Roilides, E; Romani, L; Roysuwan, P; Russell, NJ; Saggers, R; Saha, SK; Sarafidis, K; Sharland, M; Stöhr, W; Thomas, R; Tusubira, V; Velaphi, S; Vilken, T; Walker, AS; Wang, X; Wang, Y; Yang, Y; Zunjie, L | 1 |
| Chen, P; Du, Y; Feng, M; Gao, Y; Liu, H; Liu, S; Lu, Y; Qi, S; Shao, H; Sun, T; Wu, Y; Xing, L; Yang, J; Zhang, S; Zhu, Z | 1 |
| Abbey, L; Abdelghany, TM; Abdellatif, MH; Abdelmohsen, UR; Abduljaleel Alzawar, NS; Abid, MF; Abu Kasim, AFB; Abu Saad, H; Adolpho, LF; Agostini, F; Agrizii, AP; Ahmed, S; Akce, M; Åkesson, D; Al-Awaadh, AM; Al-Mutar, DMK; Al-Odayni, AB; Al-Rajhi, AMH; Alaaeldin, R; Alam, M; Alam, MM; Alanazi, MA; Alattar, H; Alawlaqi, MM; Aldebis, HK; Algehainy, NA; Almeida, AA; Aloisi, F; Alrahlah, A; Alsenani, F; Alshabib, A; Altemani, FH; Althagafi, A; Amari, A; Andronesi, AG; Antonyuk, M; Arantes, TD; Araújo, R; Arrotti, S; Asakura, T; Asib, N; Atlaskin, AA; Aung, MS; Axiaq, A; Azekawa, S; Bacon, S; Bagalagel, A; Balbinot, GS; Barnet, LS; Baroyi, SAHM; Barreto, F; Barth, Y; Barysheva, AV; Bassa, E; Basu, R; Basu, S; Bates, C; Bautista, LS; Beitl, K; Beloti, MM; Benatti, G; Benavent-Celma, C; Bentaher, A; Bergsland, N; Bernardino, AF; Bernhardt, A; Bhandari, RK; Bhaskaran, K; Bhate, K; Bhattacharjee, A; Bian, X; Bien, EM; Birch, M; Bishara, K; Biswas, JP; Bleha, R; Bocale, R; Bona, S; Boriani, G; Bouyssi, A; Bradley, D; Bravo-Sánchez, MG; Bressan, GC; Brik, A; Brizuela, A; Brockbank, KGM; Buchner, F; Bunc, M; Buscombe, JR; Butler, AJ; Buzaleh, AM; Buzin, MI; Cabrera-Capetillo, CA; Calvo, AM; Camerota, A; Campagna, G; Campisi, M; Cano, K; Cao, HST; Cardellini, S; Carvalho, AP; Carvalho, BCR; Castillo-Baltazar, OS; Cataldo, P; Chai, P; Chakraborty, S; Chalo, DM; Chan, MY; Chander, S; Changbunjong, T; Chappuis, CJF; Chee, RCH; Chen, C; Chen, CJ; Chen, E; Chen, M; Chen, X; Chen, Y; Cheng, HT; Cheng, MC; Cheow, HK; Chi, Y; Chirikova, NK; Chiu, SH; Cho, G; Cho, HR; Cho, S; Cho, SJ; Choe, A; Choe, YH; Chun, BS; Chun, Z; Cinque, A; Ciopec, M; Cladas, Y; Cleary, SP; Clermont, O; Cléroux, M; Cockburn, J; Collares, FM; Colombini-Ishikiriama, BL; Conn, BN; Cortina, JL; Cox, DRA; Crini, G; Croker, R; Cursaru, DL; Curtis, HJ; da Silva, KJG; Dalla Costa, T; Davy, S; de Araújo, BV; de Cassia Ribeiro Gonçalves, R; de Gaetano, F; de Gregorio, C; de Oliveira, MG; De Vera, MAT; de Vos, M; de-la-Fuente, I; Dell'Oca, I; Delles, M; Déméautis, T; Dempster, M; Deng, YH; Denisenko, Y; Descombes, C; Desideri, G; Devarbhavi, H; Devouassoux, G; Di Bella, G; Di Marco, F; Diao, Y; Dias, BB; Dilgin, Y; Dimopoulou, I; Dionísio, TJ; Dobrovic, A; Dokin, ES; Dolby, T; Dong, X; Dong, Y; Dou, SX; Douglas, IJ; Dousset, S; Du, Z; Duan, M; Duan, SB; Duke-Williams, O; Duteanu, N; Dutertre, S; Dutta, S; Dwyer, MG; Ebenbauer, J; Eggo, RM; El-Mordy, FMA; Elbhnsawi, NA; Elrehany, MA; Elshewemi, SS; Elwakil, BH; Emadzadeh, D; Eraso, E; Ermolenko, E; Erten, K; Ettorre, E; Evans, D; Evans, SJ; Faheem, M; Fallanza, M; Faramarzi, M; Faria, FAC; Faro, DC; Fatma, YS; Fazil, S; Feng, Y; Ferguson, J; Fernandes, MH; Fernández-Domínguez, M; Ferrari, LAL; Ferraz, EP; Ferreira, LC; Ferri, C; Fikry, M; Floris, M; Forbes, H; Fotouh, B; Franke, K; Freitas, AC; Freitas, GP; Frieboes, HB; Fu, B; Fu, Y; Fukina, DG; Fukuda, DH; Fukunaga, K; Fulham, GJ; Furlan, L; Furtado Mesa, M; Furtunescu, FL; Gabbieri, D; Ganash, M; Gebers, JC; Gehman, V; Ghaedi, A; Ghazali, NSM; Ghebrekristos, Y; Gil, J; Gilbert, NM; Gimenes, R; Giordano, L; Glehen, O; Godeau, C; Goh, SK; Goldacre, B; Gomes, AM; Gomes, MPO; Gomes, PS; Gomes, RMODS; Gómez-Coma, L; Grenho, L; Gu, Q; Gu, T; Gu, YC; Guiducci, V; Guillemin, JP; Guo, W; Guo, YW; Gur, E; Guridi, A; Guzmán-López, A; Gvozdenko, T; H Elmaidomy, A; Hagar, M; Haider, S; Han, JM; Hanratty, J; Hans, R; Haque, N; Harharah, HN; Harharah, RH; Harper, S; Hasegawa, N; Hassanin, AH; Hastuti, YP; Hatem, AE; He, R; He, Y; Heinemann, C; Heinmaa, I; Heinzl, F; Helfer, VE; Hester, F; Hickman, G; Hill, MA; Hill, WG; Hintze, V; Ho, JSY; Ho, LY; Hoang, T; Holzer, I; Houbraken, J; Hsu, CN; Hu, J; Hu, X; Hu, Y; Hua, T; Huang, Z; Hulme, WJ; Hunter, A; Ianăşi, C; Ibañez, R; Iezzi, R; Iliuță, L; Im, YM; Imran, M; Inglesby, P; Inguimbert, N; Iqbal, A; Izawa, N; Jahaj, E; Jain, S; Jakimovski, D; Jalal, MM; Jaroszuk-Ściseł, J; Jasim, DJ; Jauregizar, N; Javle, MM; Jędryczka, M; Ji, H; Jiang, Y; Jin, J; Johnson, NT; Joshi, S; Jullok, N; Kachapulula, PW; Kaczmarek, J; Kaczmarek-Szczepańska, B; Kadota, K; Kaji, M; Kakeji, Y; Kakizoe, S; Kakudidi, E; Kalitukha, L; Kamata, H; Kang, YJ; Kapinos, AA; Karakaya, S; Kashchenko, NI; Kasyanov, S; Kataky, R; Katati, B; Kato, G; Katsina, AU; Kaya, A; Kaya, H; Kazarina, OV; Ke, Y; Keenan, C; Keilson, JM; Keshavan, A; Keskinidou, C; Khalifa, MA; Khan, R; Khan, S; Kim, D; Kim, K; Kim, MS; Kim, SM; Kim, WH; Kim, Y; Kim, YJ; Kishimura, H; Kitagawa, RR; Klemenkova, ZS; Kloss, F; Kobayashi, N; Kohlhoff, M; Kong, WKF; Konsek, H; Kornaros, M; Kotanidou, A; Kovacs, S; Kraska, J; Kruppke, B; Kumagai, Y; Kumar, S; Kumari, R; Kuruva, V; Kuster, RM; Kusumoto, T; Kutyła, M; Kwon, JH; Kwon, SH; Kwong, KY; Kyser, AJ; Lackner, M; Lass-Flörl, C; Lauri, C; Lavandera, JV; Lee, BH; Lee, ECY; Lee, HJ; Lee, J; Lee, PS; Lee, S; Lee, SE; Lee, SY; Lefort, F; Leite, JPV; Leo, G; Leonard, R; Leow, AST; Lepori, N; Leyden, K; Leys, L; Ležaić, L; Li, D; Li, H; Li, J; Li, S; Li, TYW; Li, X; Li, XH; Li, Y; Li, Z; Li, ZH; Liao, S; Liaqat, K; Lim, H; Lin, BS; Lin, MY; Lin, NH; Lin, X; Lin, Y; Liu, C; Liu, H; Liu, HK; Liu, HX; Liu, P; Liu, R; Liu, T; Liu, X; Liu, Y; Lock, GA; Lokaj, G; Lopes, HB; Losi, V; Lotsios, NS; Low, KE; Lu, Z; Luhana, S; Luo, X; Luo, XQ; Lutz, MB; Lysova, AA; Lyssenko, KA; Macit, M; MacIver, B; MacKenna, B; Magalhães, GAP; Magnavacchi, P; Mahadevan, J; Mahboubi, A; Maher, SA; Mahipal, A; Mahmoud, MY; Maithel, SK; Makhtar, MMZ; Makurat-Kasprolewicz, B; Malysheva, YB; Mansourizadeh, A; Marek, EJ; Maresca-Fichter, H; Martin, JT; Maslov, AA; Mastora, Z; Mastroiacovo, D; Mastropetros, SG; Matei, D; Mathur, R; Matos, AO; Matsuda, Y; Maurya, SK; Mayor, Á; Mayrhofer, D; Mazzuco, AC; McCaffrey, J; McClure, T; McDonald, HI; Mchunu, NP; McLaggan, D; Mehrkar, A; Meilik, B; Melito, VA; Mellem, J; Mengozzi, A; Menotti, J; Mesquita, V; Miao, Z; Mihai, S; Miller, S; Minassian, C; Mirabile, A; Mitra, S; Mladin, G; Mo, Z; Moawad, H; Mohamed, EM; Mohammed, TJ; Mohanlall, V; Mohyeldin, RH; Moldovan, H; Monneret, G; Monopoli, DE; Monte, IP; Monteiro, JRB; Morgante, V; Mori, M; Morin-Crini, N; Morita, A; Morton, CE; Mrak, M; Muhammed, AP; Mulick, A; Muralidharan, V; Murthy, P; Muselli, M; Mustafa, S; Mysore Visweswariah, A; Nagao, G; Naicker, S; Nakagawara, K; Namgoong, B; Namkoong, H; Namukobe, J; Nasir, AA; Nasreen, SA; Natarajan, P; Nchiozem-Ngnitedem, VA; Necozione, S; Negrea, A; Negrea, P; Ngubane, S; Nguyen, TT; Nicke, A; Nightingale, E; Nistor, CL; Nitsch, D; Njapau, H; Noman, M; Novgorodtseva, T; Nowak, A; O'Connor, SR; Ofoe, R; Oh, K; Oh, TH; Oki, E; Olama, ZA; Olennikov, DN; Oliveira, GM; Omar, D; Ong, SJ; Orfanos, SE; Origa-Oryem, H; Orita, H; Ortiz, I; Ota, M; Ott, J; Otvagina, KV; Pacheco, N; Pacheco, RR; Padmanabhan, D; Pagan, JD; Pagnotta, PA; Palangi, V; Palanisamy, G; Palanisamy, K; Palanisamy, S; Pan, SG; Panaitescu, E; Pang, X; Panoutsakopoulos, V; Parera, VE; Park, JI; Park, JS; Park, SW; Park, Y; Park, YS; Parkash, O; Parry, J; Parry, JP; Paul, SK; Pavšič, N; Pałubicka, A; Persat, F; Petriz-Prieto, MA; Petukhov, AN; Pham, T; Pillay, S; Poh, KK; Ponomarev, II; Pontons-Melo, JC; Posa, A; Powell, E; Priya, AK; Punekar, R; Puppin Rontani, RM; Purushottam, M; Pusphanathan, K; Qi, JY; Qin, J; Qin, Z; Qiu, B; Qiu, X; Quattrini, G; Quindós, G; Qureshi, F; Rabbany, MA; Rac-Albu, M; Rac-Albu, ME; Rădulescu, BC; Rafatullah, M; Rajab, TK; Rajna, S; Ramanathan, M; Rao, D; Raviglione, D; Razorenov, DY; Redd, MJ; Rehman, W; Reig, M; Rentsch, CT; Ribeiro, LMS; Robles, D; Rocchi, S; Rocha, FG; Rodrigues, C; Rodrigues, LA; Rodrigues, RP; Roh, GH; Ronowska, A; Root, A; Rosa, AL; Rossi, R; Roy, S; Roy, VC; Rupji, M; Saber, EA; Sadarat, F; Saed, Y; Saeed, WS; Saeki, H; Saha, B; Saiwichai, T; Sakowicz-Burkiewicz, M; Sampedro, T; Sands, K; Santos, CF; Sari, M; Sathi, FA; Sauro, S; Sazanova, TS; Scafa-Udriște, A; Schoustra, SE; Schultze, A; Seo, DJ; Sevillano, E; Sezmis, G; Sgura, FA; Shah, NNAK; Shani, N; Shankarappa, B; Sharkey, LM; Sharma, VK; Sharp, C; Shehata, N; Shelton, N; Shieh, PB; Shimokawa, M; Shin, J; Shin, SH; Shin, YN; Shin, YR; Shipilova, A; Shoparwe, NF; Shukor, H; Sia, CH; Siddiqui, MH; Siddiqui, MR; Siena, V; Signore, A; Silwane, B; Siqueira-Sandrin, VS; Siregar, A; Sirignano, P; Sit, NW; Skidmore, S; Skupov, KM; Smeeth, L; Smoczer, C; Smolyanskiy, E; Sohn, H; Solodeev, I; Solovyev, A; Şomoghi, R; Song, F; Song, H; Song, Z; Souf, YM; Sousa, SC; Souza, MT; Steinbach-Rankins, JM; Stockton, J; Stout, JR; Su, K; Su, MZ; Suarez-Lopez, YA; Sukkurd, R; Sultanov, R; Sun, Y; Sun, Z; Supernak, M; Supriyono, E; Suroshe, SS; Suvorov, SS; Svera M Ianăşi, P; Switchenko, JM; Syarif, NY; Synytsya, A; Taherzadeh, MJ; Tain, YL; Tamburino, C; Tammam, OY; Tan, BYQ; Tan, H; Tan, S; Tanaka, H; Tang, R; Tang, X; Tang, Z; Taurino, M; Tazare, J; Teresi, L; Testro, A; Thanasoponkul, W; Thangarasu, S; Thavaselvam, D; Theodoro, RC; Theron, G; Thomas, RH; Thomson, JJ; Tian, X; Tian, Y; Tomaszewski, CA; Tomlinson, LA; Torres, CMME; Tóth, M; Trecourt, A; Trevisani, F; Trimarchi, G; Tristán, C; Truong, VK; Tsigkou, K; Tsutsumi, S; Ubukata, Y; Uehara, H; Uwamino, Y; Vahedi-Shahandashti, R; Valberg, SJ; Valderrama, C; Valdovinos-García, EM; Valsecchi, D; van Diepeningen, AD; van West, P; Vargas-Osuna, E; Vassall, M; Vassilaki, N; Vassiliou, AG; Vecino, X; Velez-Irizarry, D; Venkatesh, YN; Vignali, L; Virdis, A; Viswanath, B; Voisin, AS; Volkova, YA; Vorotyntsev, AV; Vorotyntsev, IV; Vtyurina, ES; Vu, DH; Waldridge, B; Walker, AJ; Wallon, M; Wang, B; Wang, G; Wang, H; Wang, J; Wang, LJ; Wang, S; Wang, T; Wang, X; Wang, Z; Warren, RM; Warren-Gash, C; Wei, SH; Weinstock-Guttman, B; Wekwejt, M; Wessjohann, LA; Wiesmann, HP; Williams, ZJ; Williamson, EJ; Wilson, M; Wing, K; Wong, AY; Wong, BKL; Woodward, S; Wozniak, KL; Wu, C; Wu, K; Wu, S; Wu, Y; Xiang, D; Xie, H; Xiong, X; Xu, C; Xu, H; Xu, J; Xu, WH; Xu, Y; Xun, T; Yamaguchi, S; Yan, P; Yan, W; Yan, Z; Yang, B; Yang, F; Yang, L; Yao, XB; Yasui, H; Yenesew, A; Yeo, LLL; Yeo, TC; Yi, S; Yin, F; Yip, JWL; Yoon, SH; Yoon, SJ; Yoshida, M; Yoshizumi, T; Young, LA; Yu, C; Yu, DD; Yu, F; Yu, H; Yu, JD; Yu, NJ; Yu, X; Yuan, Y; Yurenko, A; Yusof, YA; Zahedipoor, A; Zahran, EM; Zainuddin, NI; Zanatta, AC; Zanotto, ED; Zanozin, ID; Zavascki, AP; Zenke, M; Zhang, F; Zhang, G; Zhang, H; Zhang, J; Zhang, L; Zhang, MX; Zhang, NY; Zhang, Q; Zhang, W; Zhang, X; Zhang, XM; Zhao, F; Zhao, Q; Zhao, R; Zhao, Y; Zheng, J; Zheng, S; Zhou, L; Zhou, X; Zhu, H; Zivadinov, R; Žižek, D; Zuccoli, JR; Zwaan, BJ | 1 |
| Abebe, T; Belachew, EB; Beshah, D; Derese, SG; Desalegn, Z; Desta, AF; Gebreselasie, S; Tessema, TS; Woldemichael, GB; Zelelie, TZ | 1 |
| Bezerra, CLPAM; Boszczowski, I; Dias, MBS; Dos Santos, EL; Freire, MP; Levin, AS; Oliveira, MS; Salomão, MC | 1 |
| Boyer, P; Danion, F; Gravet, A; Hansmann, Y; Hoellinger, B; Kaeuffer, C; Lefebvre, N; Robert, A; Ruch, Y; Severac, F; Ursenbach, A | 1 |
| Lu, J; Meng, H; Niu, M; Yang, J; Zhou, Y; Zhu, H | 1 |
| Breda, GL; Funke, VAM; Lima, ACM; Loth, G; Nabhan, SK; Nogueira, KDS; Santos, ES; Tomaz, APO | 1 |
| Aponte-Barrios, N; Arcila, EM; Bravo, AM; Bustos-Paz, M; Calle, JP; Camacho-Moreno, G; Cantor, E; Cárdenas, VC; Correa, AM; Dávalos, DM; Díaz, A; Escobar, JJ; Hurtado, IC; López, P; López-Cubillos, JF; López-Medina, E; Portilla, CA; Ramirez, O; Tierradentro, TM; Torres, D | 1 |
| Barletta, JF | 1 |
| Ávila-Núñez, M; Celestino, P; García-Formoso, L; Garrido-Ventín, M; Lima, O; Martinez-Lamas, L; Pérez-Landeiro, A; Pérez-Rodríguez, MT; Represa, M; Rubianes, M; Rubiñán, P; Sousa, A; Vasallo-Vidal, F | 1 |
| Aldieri, C; Badalucco Ciotta, F; Bassetti, M; Calabresi, A; Cattardico, G; Cattelan, AM; Corcione, S; Cortegiani, A; D'Amico, F; De Rosa, FG; Del Bono, V; Del Puente, F; Di Meco, G; Di Pilato, V; Fanelli, C; Francisci, D; Giacobbe, DR; Giacomini, M; Gori, A; Graziani, L; Lombardi, A; Losito, AR; Marchese, A; Marelli, C; Mazzitelli, M; Merli, M; Mikulska, M; Milazzo, M; Momesso, E; Mularoni, A; Oltolini, C; Pallotto, C; Pontali, E; Raffaelli, F; Russelli, G; Serino, FS; Signori, A; Spinicci, M; Torti, C; Trecarichi, EM; Vena, A | 1 |
| Cui, Z; Feng, M; Wang, L | 1 |
| DeRisi, JL; Detweiler, AM; Engel, J; Hao, S; Langelier, CR; Macmillan, H; Mekonen, H; Miller, SA; Neff, N; Sanchez-Guerrero, E; Schwartz, BS; Spottiswoode, N | 1 |
| Aguado Ventura, C; Alpaca-Salvador, HA; Amaro, C; Astocondor, L; Barco-Yaipén, E; Bocangel Fernandez, C; Briones, A; Burgos, A; Campana, R; Castañeda-Sabogal, A; Castillo, K; Chincha, O; Coaquira, A; Concha-Velasco, F; Cuadros, EC; Díaz Sipión, R; Diaz, JC; Fernandez, V; García, C; Hinostroza, N; Hueda-Zavaleta, M; Ingelbeen, B; Jacobs, J; Krapp, F; López, E; Paricahua Peralta, E; Peralta Córdova, T; Pino-Dueñas, JE; Rondon, CR; Sarmiento Lopez, F; Sierra Chavez, E; Sullón Zavaleta, PA; Valera-Krumdieck, M; Vásquez, R; Vidaurre Torres, AM; Villegas-Chiroque, M | 1 |
| Chen, Y; Gao, S; Guo, Y; He, H; Hu, Y; Liu, D; Ma, X; Shan, G; Su, L; Wang, L; Zhou, X | 1 |
| Chen, WC; Cho, CF; Cho, DY; Ho, LC; Ho, MW; Hsieh, YW; Hsu, KC; Hsueh, PR; Liang, SJ; Lin, HH; Lin, YT; Tien, N; Tseng, KH; Yu, J | 1 |
| Aygen, B; Bolat, D; Dinc, G; Eren, EE; Gönen, ZB; İzci, F; Ture, Z; Ünüvar, GK; Yay, AH; Yıldız, O | 1 |
| Akalın, H; Girgin, NK; İşçimen, R; Kahveci, FŞ; Kaya, PK; Önal, U; Özakın, C; Tüzemen, NÜ | 1 |
| Aguayo Samaniego, R; Casillas Vega, N; Castillo Bejarano, JI; de la O Cavazos, ME; Espinosa Villaseñor, F; Llaca Díaz, J; Mascareñas de Los Santos, AH; Sánchez Alanís, H; Siller Rodríguez, D | 1 |
| Chaudhary, SC; Kim, B; Kim, M; Kim, Y | 1 |
| Patrier, J; Timsit, JF | 1 |
| Chen, Y; Cheng, X; He, W; Jiang, X; Li, Y; Liu, D; Ryffel, B; Shi, T; Zheng, SG; Zheng, Y | 1 |
| Bertani, AMJ; Bueno, MS; Camargo, CH; Cunha, MPV; de Barcellos, TAF; de Vasconcellos, FM; Ferreira, AM; Gonçalves, CR; Mondelli, AL; Montelli, AC; Sacchi, CT; Sadatsune, T; Sant'Ana, DA; Santos, CA; Tavares, LCB; Tiba-Casas, MR | 1 |
| Dinc, G; Doganay, M; Eren, E; Kontas, O | 1 |
| Abel da Rocha, J; Araujo Martins, I; Chamon, RC; Leite Ribeiro, R; Lopes Pires, L; Macêdo de Almeida, B; Pavoni Gomes Chagas, T; Rezende Vieira de Mendonça Souza, C; Souto Martins, I; Souza Leite, N; Zahner, V | 1 |
| Arevalo-Vidal, E; Baquerizo-Burgos, J; Bunces-Orellana, O; Bustos-Galarza, K; Ferrín-Viteri, M; Oleas, R; Puga-Tejada, M | 1 |
| Igari, H; Kawasakis, Y; Takayanagi, S; Taniguchi, T; Yahaba, M; Yamagishi, K; Yamazaki, S | 1 |
| Alves, MZO; Asensi, MD; Bandeira, CS; Beck, DS; Cid, PA; Gomes Junior, SCS; Gomes, MZR; Lima, EM; Lourenço, ND; Marques, JA; Pinheiro, LHZ; Rodrigues, CAS; Santos, RQ; Tonhá, JPS | 1 |
| Chen, G; Chen, Z; Guo, H; Guo, Z; Ma, K; Wang, Z; Zhao, G; Zhu, L | 1 |
| Alguacil-Guillén, M; Ara-Montojo, MF; de la Vega, Á; Escosa-García, L; Fernández-Camblor, C; Gómez-Gil, R; Losantos-García, I; Mellado-Peña, MJ; Plaza, D; Ramos-Boluda, E; Romero-Gómez, MP; Ruiz-Carrascoso, G; Schuffelmann-Gutiérrez, C; Seara, N; Zozaya, C | 1 |
| Ariyasu, M; Bassetti, M; Doi, Y; Echols, R; Ferrer, R; Lodise, TP; Matsunaga, Y; Naas, T; Nagata, TD; Niki, Y; Paterson, DL; Portsmouth, S; Torre-Cisneros, J; Toyoizumi, K; Wunderink, RG | 1 |
| Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
| Bollam, N; Gandra, S; Gupta, P; Mehta, Y; Sengupta, S | 1 |
| Carretero-Ledesma, M; Cebrero-Cangueiro, T; Nordmann, P; Pachón, J; Pachón-Ibáñez, ME | 1 |
| Bartzavali, C; Christofidou, M; Fligou, F; Georgakopoulou, A; Kolonitsiou, F; Marangos, M; Mplani, V; Papadimitriou-Olivgeris, M; Spiliopoulou, I | 1 |
| Avcu, G; Cilli, F; Guner Ozenen, G; Kurugol, Z; Ozkinay, F; Sahbudak Bal, Z; Tekin, D; Umit, Z | 1 |
| Chen, DQ; Chen, G; Chen, Y; Dai, M; Deng, W; Ding, X; El-Gawad El-Sayed Ahmed, MA; Galvão, KN; He, R; Huang, S; Li, HY; Liang, X; Liao, K; Lin, M; Qin, M; Roberts, AP; Tian, GB; Wu, Y; Xia, Y; Yang, Y; Zhang, L; Zhong, LL | 1 |
| Du, FL; Huang, QS; Liao, WJ; Liu, Y; Long, D; Mei, YF; Wan, LG; Wei, DD; Zhang, W | 1 |
| Chen, YC; Chuang, YC; Hsieh, SM; Hsu, JY; Wang, JT | 1 |
| Alkan, M; Ankaralı, H; Arsu, HY; Aygün, G; Balkan, II; Biçer, M; Karaali, R; Karagöz, A; Kaya, SY; Kuşkucu, M; Mete, B; Saltoğlu, N; Şen, S; Tabak, F | 1 |
| Shi, Q; Xiao, T; Xiao, Y; Yang, K; Ye, J; Zhou, Y; Zhu, Y | 1 |
| Cao, X; Guo, Y; Liu, L; Shen, X; Wang, B; Xu, Y; Yu, F; Yu, J; Zhan, Q | 1 |
| Bao, J; Ding, M; Du, G; Gu, B; Guo, L; Kang, H; Ma, Y; Wang, C; Zhou, Y | 1 |
| Brandt, C; Ferstl, PG; Filmann, N; Hogardt, M; Kempf, VAJ; Müller, M; Reinheimer, C; Waidmann, O; Zeuzem, S | 1 |
| Fan, W; Nathanson, BH; Shorr, AF; Sulham, K; Zilberberg, MD | 1 |
| Bertocchi, M; Dodi, F; Fontana, I; Marchese, A; Mariottini, G; Santori, G; Terulla, A; Varotti, G | 1 |
| Blackmore, T; Bloomfield, M | 1 |
| Liss, MA; Pruthi, DK | 1 |
| Carbo, J; Conway, EL; Kurtzhalts, K; Lin, K; Mergenhagen, KA; Ott, MC; Sellick, JA | 1 |
| Britt, NS; Burnham, CA; Durkin, MJ; Hampton, NB; Kollef, MH; Micek, ST; Ritchie, DJ | 1 |
| Katsiari, M; Mavroidi, A; Nikolaou, C; Platsouka, ED | 1 |
| Britt, NS; Burnham, CD; Durkin, MJ; Hampton, NB; Kollef, MH; Micek, ST; Ritchie, DJ | 1 |
| Choi, JK; Joo, EJ; Ko, JH; Lee, NR; Moon, SY; Park, DA; Peck, KR; Son, SK | 1 |
| Lambourne McCulloch, I; Mullens, CL; Sarwari, AR; Shreve, J; Ueno, CM | 1 |
| Bernards, ST; de Boer, MGJ; Hendriks, BJC; Lambregts, MMC; Visser, LG | 1 |
| Zaki, AOBAMES | 1 |
| Benzerara, Y; Compain, F; Constant, AL; Gallah, S; Garnier, M; Guerot, E; Labbe, V; Mainardi, JL; Montil, M; Quesnel, C; Siami, S; Vimont, S | 1 |
| Collins, M; Coultas, A; Dunne, CP; O'Connell, NH; Weinbren, M; Weston, V; Woods, S | 1 |
| Donà, D; Folgori, L; Heath, PT; Sharland, M | 1 |
| Dong, Z; Shi, L; Yang, L; Ye, G; Ye, L; Zhou, J | 1 |
| Jiang, WY; Li, FQ; Li, XY; Liu, Y; Wan, LG; Yang, JH | 1 |
| Falagas, ME; Ikawa, K; Tansarli, GS; Vardakas, KZ | 1 |
| Gupta, N; Rodrigues, C; Shetty, A; Soman, R | 1 |
| Shorr, AF; Zilberberg, MD | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F; Metan, G | 2 |
| Basu, S; Datta, S; Mitra, S; Saha, A; Viswanathan, R | 1 |
| Lortholary, O; Parize, P; Pilmis, B; Zahar, JR | 1 |
| Doi, Y; Qureshi, ZA | 1 |
| Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
| Zurawski, RM | 1 |
| Gefen-Halevi, S; Hindiyeh, MY; Keller, N; Mendelson, E; Smollan, G | 1 |
| Gonzalez-Padilla, M; López-Cerero, L; Natera, C; Pascual, A; Pontes-Moreno, A; Rivera-Espinar, F; Rivero, A; Rodríguez, M; Rodríguez-Baño, J; Rodríguez-López, F; Salcedo, I; Torre-Cisneros, J | 1 |
| Gaszynski, T; Gaszynski, W; Tokarz, A; Wieczorek, A | 1 |
| Basu, S; Chatterjee, S; Datta, S; Pal, T; Roy, S; Saha, A; Sen, B; Som, T | 1 |
| Dyer, DR; Grummet, JP; Leahy, OR; O'Reilly, M; Phillips, D | 2 |
| Brun, V; Gautier, P; Henaux, PL; Kayal, S; Kerjouan, M; Le Mouel, M; Morin, MP; Patrat-Delon, S; Piau, C; Rodriguez-Nava, V | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F | 1 |
| Chen, JC; Chen, JY; Chen, TL; Hui, CF; Pan, CY; Wu, JL | 1 |
| Abd Rahman, AN; Abdul-Aziz, MH; Lipman, J; Mat-Nor, MB; Roberts, JA; Staatz, CE; Sulaiman, H; Wallis, SC | 1 |
| Alfandari, S; Bedos, JP; Bru, JP; Gauzit, R; Pean, Y; Rabaud, C; Robert, J | 1 |
| Maksimova, OO; Martyniuk, VB; Savon, IL; Shapoval, SD; Sofilkanych, MM; Vasylevska, LA; Yakunych, AM | 1 |
| Cui, T; Su, M; Wang, J; Yan, H; Yang, H; Yang, Z; Yao, Q; Zhan, Y; Zhao, P | 1 |
| Akova, M; Almela, M; Almirante, B; Bermejo, J; Bonomo, RA; Bou, G; Calbo, E; Carmeli, Y; Cisneros, JM; García-Vázquez, E; Gasch, O; Giamarellou, H; Gracia-Ahulfinger, I; Gutiérrez-Gutiérrez, B; Hamprecht, A; Hsueh, PR; Lowman, W; Martínez-Martínez, L; Mora-Rillo, M; Oliver, A; Origüen, J; Pascual, A; Paterson, DL; Peña, C; Pérez, F; Pintado, V; Pitout, J; Prim, N; Rodríguez-Baño, J; Schwaber, MJ; Tacconelli, E; Tumbarello, M; Venditti, M; Viale, P | 1 |
| Bang, JH; Choe, PG; Kim, ES; Kim, HB; Kim, NJ; Koo, HL; Oh, MD; Park, SW; Park, WB; Song, KH; Yoon, D | 1 |
| Louie-Johnsun, MW; Yuminaga, Y | 1 |
| Bayramoğlu, G; Çamlar, SA; Dişli, Ö; Kurt, G; Özdoğan, EB | 1 |
| Cocorullo, G; Cortegiani, A; Geraci, D; Giarratano, A; Graziano, G; Mammina, C; Raineri, SM; Russotto, V; Saporito, L | 1 |
| Barreiro, FF; d'Avila, DO; Kroth, LV; Poli-de-Figueiredo, CE; Saitovitch, D; Traesel, MA | 1 |
| Abraham, P; Chaar, M; Chester, K; Curzio, K; Huang, V; Lockwood, A; Lodise, TP; Morse, B; Pai, MP; Patka, J; Rabinovich, M; Rahbar, AJ; Salomone, J; Williams, B | 1 |
| Chen, H; Chen, YG; Li, LJ; Li, YM; Praseedom, RK; Xie, HY; Zhang, Y; Zheng, SS; Zhou, L | 1 |
| Cleveland, KO; Gelfand, MS | 1 |
| Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
| Deb, M; Gaind, R; Mohanty, S; Ranjan, R | 1 |
| Adam, HJ; DeCorby, M; Hoban, DJ; Karlowsky, JA; Rennie, R; Zhanel, GG | 1 |
| Limmathurotsakul, D; Peacock, SJ | 1 |
| Ben-David, D; Gal-Mor, O; Keller, N; Kordevani, R; Maor, Y; Marzel, A; Rahav, G; Tal, I | 1 |
| Beloborodov, VB; Gruver, KP; Kuz'menko, TN | 1 |
| López, M; Martín, C; Rojo-Bezares, B; Sáenz, Y; Torres, C | 1 |
| Hukić, M; Siširak, M | 1 |
| Chong, Y; Jeon, J; Kim, JW; Lee, K; Yong, D | 1 |
| Chai, LY; Chee, YL; Chng, WJ; Ding, Y; Hsu, LY; Jin, J; Lee, YM; Poon, LM; Tan, LK | 1 |
| Akiyama, N; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A | 1 |
| Nakahama, C | 1 |
| Ohnishi, K | 1 |
| Oishi, K | 1 |
| Kohno, S | 1 |
| Endo, M; Gondaira, F; Hatakeyama, K; Iwakura, N; Iwaya, A; Kurihara, M; Kuwano, T; Nakagawa, S; Taneike, I; Yamamoto, T | 1 |
| Borgmann, S; Heeg, P; Kötter, I; Mayer, F; Riessen, R; Weyrich, P | 1 |
| Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P | 1 |
| Barauskas, G; Dambrauskas, Z; Gulbinas, A; Pundzius, J | 1 |
| Bloos, F | 1 |
| Beuscart, C; Mouton, YJ | 1 |
| Sjursen, H; Solberg, CO | 1 |
| Asano, K; Fuse, A; Hashizume, T; Nagano, R; Naito, T; Nakagawa, S; Shibata, K | 1 |
| Domon, H; Furuya, N; Ishii, K; Matsumoto, T; Miyazaki, S; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
| Horii, T; Ichiyama, S; Kobayashi, M; Nadai, M; Ohta, M | 1 |
| Mészáros, J | 1 |
| Bergholm, AM; Dornbusch, K | 1 |
| Dornbusch, K; Göransson, E; Kronvall, G; Mörtsell, E | 1 |
21 review(s) available for carbapenems and Blood Poisoning
| Article | Year |
|---|---|
Management of Infections Caused by Multidrug-resistant Gram-negative Pathogens: Recent Advances and Future Directions.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Sepsis | 2021 |
A meta-analysis for the role of aminoglycosides and tigecyclines in combined regimens against colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Tigecycline | 2022 |
Efficacy and Safety of Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Humans; Microbial Sensitivity Tests; Sepsis | 2022 |
Carbapenem-resistant Gram-negative pathogens associated with septic shock: a review of 120 cases.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Shock, Septic | 2022 |
Comparison of Duration and Empiric Antibiotic Choice of Post-Operative Treatment in Abdominal Sepsis.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Intraabdominal Infections; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2022 |
Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Communicable Diseases; Gram-Negative Bacteria; Humans; Organ Transplantation; Sepsis | 2022 |
Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Lactams; Randomized Controlled Trials as Topic; Sepsis | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Carbapenem use in critically ill patients.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteria; beta-Lactam Resistance; Carbapenems; Critical Illness; Humans; Intensive Care Units; Prescription Drug Overuse; Sepsis | 2020 |
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
Clinical effectiveness of carbapenems versus alternative antibiotics for treating ESBL-producing Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Sepsis; Treatment Outcome | 2018 |
Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms.
Topics: Adolescent; Age Factors; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; Clinical Trials as Topic; Disease Management; Female; Humans; Infant; Infant, Newborn; Male; Prognosis; Sepsis; Treatment Outcome | 2019 |
Escherichia coli sequence type 131: epidemiology and challenges in treatment.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Cystitis; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; United States | 2014 |
Carbapenem-resistant enterobacteriaceae: occult threat in the intensive care unit.
Topics: Anti-Bacterial Agents; Carbapenems; Critical Care Nursing; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Humans; Infection Control; Intensive Care Units; Minocycline; Sepsis; Tigecycline | 2014 |
[STRATEGY OF ANTIBACTERIAL THERAPY OF SEPSIS. PART I].
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Typing Techniques; Blood Specimen Collection; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Sepsis | 2015 |
Melioidosis: a clinical overview.
Topics: Anti-Infective Agents; Asia, Southeastern; Australia; Burkholderia pseudomallei; Carbapenems; Ceftazidime; Communicable Disease Control; Disease Reservoirs; Global Health; Humans; Melioidosis; Recurrence; Risk Assessment; Sepsis; Seroepidemiologic Studies; Serologic Tests | 2011 |
[Klebsiella infection].
Topics: 4-Quinolones; Anti-Infective Agents; beta-Lactamases; Carbapenems; Cephalosporins; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Penicillinase; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 2003 |
[Campylobacter infection].
Topics: Anti-Bacterial Agents; Campylobacter fetus; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Endocarditis; Gastroenteritis; Guillain-Barre Syndrome; Humans; Macrolides; Meningitis, Bacterial; Miller Fisher Syndrome; Prognosis; Sepsis; Zoonoses | 2003 |
[Pseudomonas aeruginosa infection].
Topics: 4-Quinolones; Anti-Infective Agents; Bacteremia; Biofilms; Carbapenems; Cephalosporins; Fimbriae, Bacterial; Flagella; Humans; Immunocompromised Host; Multidrug Resistance-Associated Proteins; Prognosis; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Trans-Activators; Urinary Tract Infections | 2003 |
Meta-analysis of prophylactic parenteral antibiotic use in acute necrotizing pancreatitis.
Topics: Antibiotic Prophylaxis; Carbapenems; Data Interpretation, Statistical; Evidence-Based Medicine; Humans; Imipenem; Incidence; Injections, Intravenous; Necrosis; Odds Ratio; Pancreas; Pancreatitis, Acute Necrotizing; Pefloxacin; Prevalence; Randomized Controlled Trials as Topic; Risk; Risk Factors; Sepsis; Time Factors; Tomography, X-Ray Computed | 2007 |
[Severe infections and sepsis--the rules of empirical chemotherapy].
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Therapy, Combination; Glycopeptides; Humans; Sepsis; Shock, Septic | 2001 |
9 trial(s) available for carbapenems and Blood Poisoning
| Article | Year |
|---|---|
Polymyxin B therapy based on therapeutic drug monitoring in carbapenem-resistant organisms sepsis: the PMB-CROS randomized clinical trial.
Topics: Acute Kidney Injury; Carbapenems; Drug Monitoring; Humans; Polymyxin B; Sepsis | 2023 |
Topics: Acetogenins; Acute Disease; Acute Kidney Injury; Administration, Intravenous; Aged; Albumins; Alcoholism; Aldehyde Dehydrogenase; Aldehyde Dehydrogenase, Mitochondrial; alpha-Glucosidases; Anemia; Animals; Anthozoa; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Antigens, Bacterial; Antihypertensive Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Ascites; Asthma; Bacteria; beta-Lactamases; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Binding Sites; Biological Availability; Biomass; Borderline Personality Disorder; Brain; Brucella abortus; Brucella melitensis; Brucellosis; Calcium; Carbapenems; Case-Control Studies; Caseins; Cattle; CD8-Positive T-Lymphocytes; Ceftaroline; Cell Line; Cell Line, Tumor; Cell Physiological Phenomena; Cell Proliferation; Cephalosporins; Chemotherapy, Adjuvant; China; Chitin; Chlorella; Chlorophyll; Chlorophyll A; Chlorophyta; Cholangiocarcinoma; Cisplatin; Conotoxins; Contrast Media; Conus Snail; Cross-Sectional Studies; Cytokines; Decapodiformes; Deoxycytidine; Diagnostic and Statistical Manual of Mental Disorders; Dietary Fiber; Diterpenes; DNA Methylation; Dogs; Double-Blind Method; Drug Design; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; Eicosapentaenoic Acid; Enzyme-Linked Immunosorbent Assay; Epidermis; Escherichia coli; Escherichia coli Infections; Extraintestinal Pathogenic Escherichia coli; Fatty Acids; Fatty Acids, Unsaturated; Fatty Acids, Volatile; Feasibility Studies; Feces; Female; Ferritins; Fluorodeoxyglucose F18; Gastrectomy; Gastrointestinal Microbiome; Gemcitabine; Glomerular Filtration Rate; Glucose; Glycerol; Granulocyte-Macrophage Colony-Stimulating Factor; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Immunoassay; Immunoglobulin G; India; Infant, Newborn; Infertility; Inflammation; Intensive Care Units; Iron; Iron Deficiencies; Kidney; Lacticaseibacillus rhamnosus; Laurencia; Leukocytes; Lipids; Liver Cirrhosis; Long Interspersed Nucleotide Elements; Longitudinal Studies; Male; Mesenchymal Stem Cells; Methicillin-Resistant Staphylococcus aureus; Mice; Microalgae; Microbial Sensitivity Tests; Microscopy; Middle Aged; Minerals; Molecular Conformation; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Nephropidae; Nicotinic Antagonists; Nitrogen; Obesity; Oxaliplatin; Paclitaxel; Panax; Pancreatic Neoplasms; Pancreatitis; Personality; Personality Disorders; Personality Inventory; Photobioreactors; Plant Extracts; Plasmalogens; Plasmids; Polymorphism, Genetic; Polynesia; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prebiotics; Predictive Value of Tests; Prognosis; Prolyl-Hydroxylase Inhibitors; Rabbits; Radiopharmaceuticals; Rats; Rats, Wistar; Receptors, Nicotinic; Recombinant Proteins; Retrospective Studies; Rifampin; Risk Factors; RNA, Ribosomal, 16S; Salinity; Seaweed; Sensitivity and Specificity; Sepsis; Sesquiterpenes; Severity of Illness Index; Shock, Septic; Silicones; Single Photon Emission Computed Tomography Computed Tomography; Skin; Snails; Solubility; Solvents; Sputum; Staphylococcal Infections; Stomach Neoplasms; Stramenopiles; Structure-Activity Relationship; Technetium Tc 99m Exametazime; Technology; Terpenes; Tuberculosis; Tuberculosis, Multidrug-Resistant; Urinary Catheters; Urinary Tract Infections; Vascular Endothelial Growth Factor A; Virulence Factors; Water; Wound Healing | 2023 |
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Cephalosporins; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Sepsis; Urinary Tract Infections; Young Adult | 2021 |
Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive ca
Topics: beta-Lactam Resistance; beta-Lactamases; Carbapenems; Deprescriptions; Enterobacteriaceae Infections; Equivalence Trials as Topic; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Microbial Sensitivity Tests; Mortality; Recurrence; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 2019 |
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Female; Humans; Male; Middle Aged; Retrospective Studies; Sepsis; Survival Analysis; Treatment Outcome | 2016 |
Thymosin alpha1- and ulinastatin-based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem-resistant bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria; Carbapenems; Cholangitis; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Glycoproteins; Humans; Immunologic Factors; Intestinal Obstruction; Liver Abscess; Male; Middle Aged; Pancreatitis; Peritonitis; Sepsis; Thymalfasin; Thymosin | 2008 |
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis | 2006 |
Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.
Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbapenems; Ceftazidime; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Respiratory Tract Infections; Sepsis; Thienamycins; Time Factors; Treatment Outcome; Urinary Tract Infections | 1995 |
Safety and efficacy of meropenem in patients with septicaemia: a randomised comparison with ceftazidime, alone or combined with amikacin.
Topics: Adult; Aged; Amikacin; Carbapenems; Ceftazidime; Drug Therapy, Combination; Drug Tolerance; Hospitalization; Humans; Meropenem; Middle Aged; Sepsis; Thienamycins; Treatment Outcome | 1995 |
141 other study(ies) available for carbapenems and Blood Poisoning
| Article | Year |
|---|---|
The investigation of adrenal involvement in carbapenem resistant Acinetobacter baumannii sepsis: experimental mouse model
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adrenal Insufficiency; Animals; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Corticosterone; Female; Mice; Microbial Sensitivity Tests; Sepsis | 2021 |
The epidemiology of bloodstream infections and antimicrobial susceptibility patterns in Thuringia, Germany: a five-year prospective, state-wide surveillance study (AlertsNet).
Topics: Aged; Aged, 80 and over; Candida; Carbapenems; Drug Resistance, Microbial; Enterococcus faecium; Escherichia coli; Germany; Humans; Klebsiella pneumoniae; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Prospective Studies; Sepsis; Staphylococcus epidermidis; Vancomycin Resistance | 2021 |
Clinical outcome from hematopoietic cell transplant patients with bloodstream infection caused by carbapenem-resistant P. aeruginosa and the impact of antimicrobial combination in vitro.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Brazil; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Young Adult | 2022 |
Risk factors for bloodstream infection by multidrug-resistant organisms in critically ill patients in a reference trauma hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Critical Illness; Drug Resistance, Multiple, Bacterial; Enterococcus; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Risk Factors; Sepsis | 2022 |
A host-directed macrocyclic peptide therapeutic for MDR gram negative bacterial infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cytokines; Drug Design; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Gram-Negative Bacterial Infections; Humans; Inflammation; Klebsiella pneumoniae; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Phagocytosis; Sepsis | 2021 |
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Humans; Microbial Sensitivity Tests; Sepsis | 2021 |
Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.
Topics: Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Molecular Epidemiology; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Immunoassay; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sensitivity and Specificity; Sepsis | 2022 |
A retrospective observational cohort study of the clinical epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae in an OXA-48 endemic setting.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Adipose tissue is a predictor of 30-days mortality in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae.
Topics: Adipose Tissue; Anti-Bacterial Agents; Bacteremia; Carbapenems; COVID-19; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; SARS-CoV-2; Sepsis | 2022 |
Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prospective Studies; Sepsis | 2022 |
Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Colistin; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis | 2022 |
Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan.
Topics: Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Humans; Japan; Retrospective Studies; Sepsis; Treatment Outcome | 2022 |
Incidence, etiology, risk factors, and outcomes of pre-engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation.
Topics: Bacteremia; Bacteria; Carbapenems; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Risk factors and mortality for elderly patients with bloodstream infection of carbapenem resistance Klebsiella pneumoniae: a 10-year longitudinal study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Humans; Hypertension; Klebsiella Infections; Klebsiella pneumoniae; Longitudinal Studies; Retrospective Studies; Risk Factors; Sepsis | 2022 |
Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Liver Transplantation; Retrospective Studies; Risk Factors; Sepsis; Transplant Recipients | 2023 |
Genomic Epidemiology of Carbapenemase-Producing and Colistin-Resistant
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Enterobacteriaceae; Ethiopia; Genomics; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis | 2022 |
Emergence of a Novel NDM-5-Producing Sequence Type 4523 Klebsiella pneumoniae Strain Causing Bloodstream Infection in China.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Female; Formaldehyde; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis | 2022 |
Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cohort Studies; Humans; Retrospective Studies; Sepsis | 2022 |
Trends of Bloodstream Infections in a University Hospital During 12 Years.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Coagulase; Colistin; Escherichia coli; Hospitals, University; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2022 |
Bloodstream infections and antibiotic resistance patterns: a six-year surveillance study from southern Italy.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Escherichia coli; Humans; Italy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2023 |
Clinical and Molecular Characterizations of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Hospital.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Sepsis | 2022 |
Whole genome sequencing of OXA-232-producing
Topics: Amikacin; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromosomes; Ciprofloxacin; DNA Transposable Elements; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Plasmids; Sepsis; Virulence; Virulence Factors; Whole Genome Sequencing | 2022 |
Rhamnetin, a Natural Flavonoid, Ameliorates Organ Damage in a Mouse Model of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carbapenems; Disease Models, Animal; Escherichia coli; Flavonoids; Mice; Microbial Sensitivity Tests; Sepsis | 2022 |
Risk Factors for 30-Day Mortality in Neonates With Carbapenem-resistant A. baumannii Sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Infant, Newborn; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Sepsis; Thrombocytopenia | 2022 |
Large increase in bloodstream infections with carbapenem-resistant
Topics: Acinetobacter; Anti-Bacterial Agents; Carbapenems; COVID-19; Drug Resistance, Bacterial; Humans; Pandemics; Sepsis | 2022 |
Characteristics of bloodstream infection and initial antibiotic use in critically ill burn patients and their impact on patient prognosis.
Topics: Anti-Bacterial Agents; Burns; Carbapenems; China; Critical Illness; Humans; Klebsiella pneumoniae; Lincomycin; Prognosis; Retrospective Studies; Sepsis | 2022 |
Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sepsis | 2022 |
Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study.
Topics: Adult; Anti-Infective Agents; Bacteremia; Carbapenems; Humans; Neutropenia; Pseudomonas aeruginosa; Retrospective Studies; Sepsis | 2022 |
Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Topics: Adult; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Hematologic Neoplasms; Humans; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic; Tertiary Care Centers | 2022 |
Cefiderocol as Salvage Therapy for Carbapenem-Resistant Klebsiella pneumoniae Sepsis in an Extremely Preterm Neonate.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cefiderocol; Humans; Infant, Extremely Premature; Infant, Newborn; Klebsiella pneumoniae; Microbial Sensitivity Tests; Salvage Therapy; Sepsis | 2023 |
Clinical and bacteriological profile of culture-negative and culture-proven neonatal sepsis in Palembang, Indonesia.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Indonesia; Infant, Newborn; Neonatal Sepsis; Sepsis | 2022 |
Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Gram-Negative Bacterial Infections; Humans; Neutropenia; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Sepsis; Stenotrophomonas maltophilia | 2023 |
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network).
Topics: Anti-Bacterial Agents; Carbapenems; Gram-Negative Bacteria; Humans; Italy; Prospective Studies; Sepsis | 2023 |
Pathogens distribution and antimicrobial resistance pattern of blood stream infections in Southern Italian hospital, 2016-2021 surveillance.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Hospitals; Humans; Italy; Klebsiella pneumoniae; Pseudomonas aeruginosa; Sepsis; Staphylococcus aureus | 2023 |
Cost-effectiveness analysis of ceftazidime-avibactam as definitive treatment for treatment of carbapenem-resistant
Topics: Carbapenems; Cost-Effectiveness Analysis; Humans; Klebsiella pneumoniae; Sepsis; United States | 2023 |
Customized molecular diagnostics of bacterial bloodstream infections for carbapenem resistance: A convenient and affordable approach.
Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Proteins; Carbapenems; Humans; Microbial Sensitivity Tests; Pathology, Molecular; Sepsis | 2023 |
Risk factors and molecular epidemiology of bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Epidemiology; Multilocus Sequence Typing; Observational Studies as Topic; Phylogeny; Risk Factors; Sepsis | 2023 |
Efficacy of Carbapenems Compared With Noncarbapenem Broad-Spectrum Beta-Lactam Antibiotics as Initial Antibiotic Therapy Against Sepsis: A Nationwide Observational Study.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Hospital Mortality; Humans; Monobactams; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Treatment Outcome | 2023 |
[Application of Rapid Detection Method Based on NG-Test® CARBA 5 in Bloodstream Infections Associated With Carbapenem-Resistant Enterobacterales].
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis | 2023 |
Epidemiology and risk factors of 28-day mortality of hospital-acquired bloodstream infection in Turkish intensive care units: a prospective observational cohort study.
Topics: Bacteremia; Carbapenems; Cohort Studies; COVID-19; Cross Infection; Female; Hospitals; Humans; Intensive Care Units; Male; Prospective Studies; Risk Factors; Sepsis | 2023 |
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS).
Topics: Anti-Bacterial Agents; Carbapenems; Cohort Studies; Humans; Infant; Infant, Newborn; Neonatal Sepsis; Prospective Studies; Sepsis | 2023 |
High burden of ESBL and carbapenemase-producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Cesarean Section; Cross-Sectional Studies; Ethiopia; Female; Gram-Negative Bacteria; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pregnancy; Sepsis; Tertiary Care Centers | 2023 |
Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort.
Topics: Anti-Bacterial Agents; Carbapenems; COVID-19; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Polymyxins; Retrospective Studies; Sepsis | 2023 |
Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective study.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Enterobacteriaceae; Enterobacteriaceae Infections; Gammaproteobacteria; Humans; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2023 |
Risk factors and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae bacteraemia in children: a retrospective study.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic | 2023 |
Colonization by multidrug-resistant bacteria in hematological patients undergoing hematopoietic stem cell transplantation and clinical outcomes: A single-center retrospective cohort study.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Hematopoietic Stem Cell Transplantation; Humans; Klebsiella pneumoniae; Neutropenia; Retrospective Studies; Sepsis | 2023 |
Carbapenem resistance in Enterobacterales bloodstream infections among children with cancer or post-haematopoietic stem cell transplant: a retrospective cohort study.
Topics: Adolescent; Anti-Bacterial Agents; Carbapenems; Child; Female; Gammaproteobacteria; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasms; Retrospective Studies; Sepsis | 2023 |
Empiric Carbapenem Therapy for Sepsis: Are We Winning the Battle at the Expense of the War?
Topics: Carbapenems; Humans; Sepsis | 2023 |
Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales.
Topics: Adult; Aged; Bacteremia; Carbapenems; Cefepime; Humans; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2023 |
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Disease Susceptibility; Drug Combinations; Humans; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Sepsis | 2023 |
Clinical and Epidemiological Characteristics of Carbapenem-Resistant
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Retrospective Studies; Sepsis; Tertiary Care Centers; Tigecycline | 2023 |
In host evolution of beta lactam resistance during active treatment for
Topics: Bacteremia; beta-Lactam Resistance; Carbapenems; Humans; Pseudomonas aeruginosa; Sepsis; United States | 2023 |
Prevalence of Antimicrobial Resistance in Gram-Negative Bacteria Bloodstream Infections in Peru and Associated Outcomes: VIRAPERU Study.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Peru; Prevalence; Pseudomonas aeruginosa; Sepsis | 2023 |
Carbapenem is not always the best choice in the treatment of septic shock.
Topics: Anti-Bacterial Agents; Carbapenems; China; Humans; Sepsis; Shock, Septic | 2023 |
Prediction of methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae from flagged blood cultures by combining rapid Sepsityper MALDI-TOF mass spectrometry with machine learning.
Topics: Blood Culture; Carbapenems; Humans; Klebsiella pneumoniae; Machine Learning; Methicillin-Resistant Staphylococcus aureus; Sepsis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus | 2023 |
The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Fosfomycin; Interleukin-6; Mesenchymal Stem Cells; Mice; Microbial Sensitivity Tests; Sepsis | 2023 |
Evaluation of the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis | 2023 |
Case Report: Molecular Characterization of Bloodstream Infections due to Carbapenem-Resistant Acinetobacter baumannii: A Pediatric Case Series.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Humans; Infant, Newborn; Microbial Sensitivity Tests; Retrospective Studies; Sepsis | 2023 |
Protective Effects of Rhamnetin in Carbapenem-Resistant
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Carbapenems; Cytokines; Lipopolysaccharides; Mice; Microbial Sensitivity Tests; Reactive Oxygen Species; Sepsis; Shock, Septic; Toll-Like Receptor 4 | 2023 |
Secoeudesma sesquiterpenes lactone A alleviates inflammation and offers adjuvant protection in severe infection of carbapenem-resistant Klebsiella pneumoniae.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carbapenems; Cytokines; Drug Resistance, Bacterial; Female; Inula; Klebsiella Infections; Klebsiella pneumoniae; Lactones; Lipopolysaccharides; Mice; Mice, Inbred C57BL; RAW 264.7 Cells; Sepsis; Sesquiterpenes | 2020 |
Genomic and Clinical Characterization of IMP-1-Producing Multidrug-Resistant
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Integrons; Microbial Sensitivity Tests; Sepsis; Tertiary Care Centers | 2020 |
The efficacy of mesenchymal stem cell therapy in experimental sepsis induced by carbapenem-resistant K. pneumoniae in neutropenic mice model.
Topics: Animals; Carbapenems; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Female; Klebsiella pneumoniae; Mesenchymal Stem Cell Transplantation; Mice; Mice, Inbred BALB C; Neutropenia; Sepsis | 2020 |
KPC-2 producing Pseudomonas putida as an unexpected pathogen of catheter-associated bloodstream infection.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Catheter-Related Infections; Drug Resistance, Bacterial; Humans; Immunocompromised Host; Male; Pseudomonas putida; Sepsis | 2020 |
Carbapenems versus ciprofloxacin/metronidazole for decreasing complications and hospital stay following complicated acute appendicitis surgery: A prospective cohort in an Ecuadorian population.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Appendectomy; Appendicitis; Carbapenems; Ciprofloxacin; Comorbidity; Drug Therapy, Combination; Ecuador; Emergencies; Female; Humans; Length of Stay; Male; Metronidazole; Middle Aged; Postoperative Complications; Prospective Studies; Sepsis; Young Adult | 2020 |
A retrospective observational study of antibiotics treatment for sepsis using a nationwide claim database in Japan.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Humans; Japan; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis | 2020 |
Predictive factors for sepsis by carbapenem resistant Gram-negative bacilli in adult critical patients in Rio de Janeiro: a case-case-control design in a prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Case-Control Studies; Critical Illness; Cross Infection; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Sepsis; Tertiary Care Centers; Young Adult | 2020 |
Successful Treatment of Early Post-Transplant Bloodstream and Pulmonary Infection Caused by Carbapenem-Resistant Klebsiella pneumoniae With a Combination of Ceftazidime-Avibactam and Carbapenem: A Case Report.
Topics: Adult; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Therapy, Combination; Female; Humans; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Respiratory Tract Infections; Sepsis; Transplant Recipients | 2020 |
Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Enterobacteriaceae Infections; Humans; Retrospective Studies; Sepsis | 2021 |
Risk factors associated with carbapenem-resistant
Topics: Carbapenems; Humans; Klebsiella pneumoniae; Risk Factors; Sepsis; Tertiary Care Centers | 2021 |
Efficacy of dual carbapenem treatment in a murine sepsis model of infection due to carbapenemase-producing Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Female; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Sepsis | 2021 |
External validation of INCREMENT-CPE score in a retrospective cohort of carbapenemase-producing Klebsiella pneumoniae bloodstream infections in critically ill patients.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cohort Studies; Critical Illness; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reproducibility of Results; Retrospective Studies; Sepsis | 2021 |
Nosocomial Non-fermentative gram negative bacteria bloodstream infections in children; Risk factors and clinical outcomes of carbapenem resistance.
Topics: Anti-Bacterial Agents; Carbapenems; Child; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Retrospective Studies; Risk Factors; Sepsis | 2021 |
Molecular characterization of carbapenem-resistant and virulent plasmids in
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Moths; Phylogeny; Sepsis; Virulence | 2021 |
Prevalence of Carbapenem-Resistant
Topics: beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Prevalence; Sepsis; Virulence | 2020 |
Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: Risk factors, mortality, and antimicrobial susceptibility, 2017-2019.
Topics: Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Delivery of Health Care; Humans; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors; Sepsis | 2021 |
Colistin resistance increases 28-day mortality in bloodstream infections due to carbapenem-resistant Klebsiella pneumoniae.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Proportional Hazards Models; Retrospective Studies; Sepsis | 2021 |
Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China.
Topics: Bacteremia; Carbapenems; China; Humans; Pseudomonas aeruginosa; Retrospective Studies; Risk Factors; Sepsis; Socioeconomic Factors | 2021 |
Distribution of fluoroquinolone resistance determinants in Carbapenem-resistant Klebsiella pneumoniae clinical isolates associated with bloodstream infections in China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; China; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pneumoniae; Multilocus Sequence Typing; Plasmids; Sepsis | 2021 |
Preliminary exploration on the serum biomarkers of bloodstream infection with carbapenem-resistant Klebsiella pneumoniae based on mass spectrometry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Biomarkers; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Enterobacteriaceae Infections; Female; Humans; Male; Mass Spectrometry; Mice; Mice, Inbred ICR; Middle Aged; Peptide Fragments; Sepsis; Young Adult | 2021 |
The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.
Topics: Adult; Aged; Aged, 80 and over; Carbapenems; Chi-Square Distribution; Drug Resistance, Multiple, Bacterial; Female; Germany; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Kaplan-Meier Estimate; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Retrospective Studies; Risk Factors; Sepsis; Time Factors; Treatment Outcome; Young Adult | 2017 |
Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Health Care Costs; Hospital Mortality; Hospitalization; Humans; Inappropriate Prescribing; Length of Stay; Male; Middle Aged; Pneumonia; Prevalence; Retrospective Studies; Risk Factors; Sepsis; Treatment Outcome; Urinary Tract Infections | 2017 |
Impact of carbapenem-resistant Klebsiella pneumoniae (CR-KP) infections in kidney transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Delayed Graft Function; Disease Outbreaks; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Humans; Incidence; Italy; Kaplan-Meier Estimate; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Matched-Pair Analysis; Middle Aged; Retrospective Studies; Sepsis | 2017 |
Prophylactic ciprofloxacin for prostate biopsy: a losing bet?
Topics: Anti-Bacterial Agents; Biopsy; Carbapenems; Ciprofloxacin; Humans; Male; Prostate; Sepsis | 2017 |
Rational antibiotic sustainability for transrectal prostate biopsy prophylaxis.
Topics: Anti-Bacterial Agents; Biopsy; Carbapenems; Humans; Male; Prostate; Sepsis | 2017 |
Impact of Penicillin Allergy on Time to First Dose of Antimicrobial Therapy and Clinical Outcomes.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Hypersensitivity; Emergency Service, Hospital; Female; Hospitalization; Humans; Male; Middle Aged; Patient Readmission; Penicillins; Pneumonia; Retrospective Studies; Sepsis; Urinary Tract Infections | 2017 |
Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.
Topics: Adult; Aged; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Urinary Tract Infections | 2018 |
Extensively drug-resistant Acinetobacter baumannii bacteraemia in a multidisciplinary intensive care unit during a 6-year period: Risk factors for fulminant sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Sepsis | 2018 |
Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?
Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Inpatients; Sepsis | 2018 |
Considerations for Systemic and Topical Treatment of Morganella morganii Septicemia Arising from Maggot Infestation.
Topics: Administration, Intravenous; Administration, Topical; Aged, 80 and over; Carbapenems; Enterobacteriaceae Infections; Humans; Hydrotherapy; Hyperkeratosis, Epidermolytic; Insecticides; Lower Extremity; Male; Morganella morganii; Myiasis; Ointments; Permethrin; Postthrombotic Syndrome; Sepsis; Treatment Outcome | 2018 |
Using local clinical and microbiological data to develop an institution specific carbapenem-sparing strategy in sepsis: a nested case-control study.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Cephalosporins; Cohort Studies; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 2019 |
Molecular Study of Klebsiella Pneumoniae Virulence Genes from Patients with Hospital Acquired Sepsis.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis; Virulence | 2019 |
Oxygenating the argument for consistent performance of anaerobic blood cultures and blood volumes collected.
Topics: Anaerobiosis; beta-Lactamases; Blood Culture; Blood Volume; Carbapenems; Cohort Studies; Emergency Service, Hospital; Humans; Sepsis | 2019 |
Challenges in diagnosing community-acquired carbapenem-susceptible Acinetobacter baumannii enterogenic sepsis: A case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Community-Acquired Infections; Humans; Intestinal Diseases; Male; Microbial Sensitivity Tests; Sepsis | 2019 |
Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae isolates of sequence type 11 at a university hospital in China.
Topics: Anti-Bacterial Agents; Carbapenems; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Hospitals, University; Humans; Infant; Integrons; Klebsiella pneumoniae; Multilocus Sequence Typing; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, DNA | 2013 |
Reply to Soman et al and Frippiat et al.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Are prolonged/continuous infusions of β-lactams for all?
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Carbapenems; Female; Humans; Male; Penicillanic Acid; Piperacillin; Sepsis | 2013 |
Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
Topics: Adult; Aged; Carbapenems; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia, Bacterial; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; United States; Young Adult | 2013 |
Carbapenem-resistant Klebsiella pneumoniae sepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Klebsiella pneumoniae; Methylprednisolone; Methylprednisolone Acetate; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Structure-Activity Relationship; Tigecycline | 2014 |
Characterization of novel plasmid-mediated β-lactamases (SHV-167 and ACT-16) associated with New Delhi metallo-β-lactamase-1 harbouring isolates from neonates in India.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; India; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Plasmids; Sepsis; Sequence Analysis, DNA | 2014 |
Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Sulbactam; Tigecycline; Time Factors | 2013 |
Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephamycins; Child; Child, Preschool; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Retrospective Studies; Sepsis; Urinary Tract Infections | 2014 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
Molecular detection of antibiotic resistance genes from positive blood cultures.
Topics: Anti-Bacterial Agents; Automation, Laboratory; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Culture Media; DNA Primers; Gene Expression; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Real-Time Polymerase Chain Reaction; Reference Standards; Ribonuclease P; Sepsis | 2015 |
Gentamicin therapy for sepsis due to carbapenem-resistant and colistin-resistant Klebsiella pneumoniae.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Colistin; Disease Outbreaks; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Sepsis; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
The doripenem serum concentrations in intensive care patients suffering from acute kidney injury, sepsis, and multi organ dysfunction syndrome undergoing continuous renal replacement therapy slow low-efficiency dialysis.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Carbapenems; Critical Care; Doripenem; Humans; Microbial Sensitivity Tests; Middle Aged; Multiple Organ Failure; Renal Dialysis; Sepsis | 2014 |
A five-year experience of carbapenem resistance in Enterobacteriaceae causing neonatal septicaemia: predominance of NDM-1.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Humans; Infant, Newborn; Male; Porins; Sepsis | 2014 |
Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Humans; Image-Guided Biopsy; Male; Middle Aged; Prostatic Diseases; Retrospective Studies; Sepsis; Ultrasonography | 2015 |
First case of disseminated infection with Nocardia cerradoensis in a human.
Topics: Aminoglycosides; Anti-Bacterial Agents; Brain; Carbapenems; Cluster Analysis; DNA Gyrase; DNA, Bacterial; DNA, Ribosomal; Female; Heat-Shock Proteins; Humans; Kidney Transplantation; Microbial Sensitivity Tests; Microscopy; Middle Aged; Molecular Sequence Data; Nocardia; Nocardia Infections; Phylogeny; Radiography, Abdominal; Radiography, Thoracic; RNA, Ribosomal, 16S; Sepsis; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Transplant Recipients; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2015 |
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline | 2015 |
Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Behavior, Animal; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fish Proteins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Protein Isoforms; Recombinant Proteins; Sepsis; Survival Analysis; Tilapia | 2015 |
Population Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.
Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Creatinine; Critical Illness; Doripenem; Female; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; Models, Statistical; Monte Carlo Method; Prospective Studies; Pseudomonas aeruginosa; Sepsis; Survival Analysis | 2016 |
Carbapenem use in French hospitals: A nationwide survey at the patient level.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; France; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis; Surveys and Questionnaires; Young Adult | 2015 |
Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Tablets | 2016 |
The purpose and appropriateness of carbapenem use in a single university hospital, 2009-2013.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Hospitals, University; Humans; Inappropriate Prescribing; Practice Patterns, Physicians'; Retrospective Studies; Sepsis; Shock, Septic | 2016 |
Re: Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Biopsy, Needle; Carbapenems; Humans; Prostate; Prostatic Neoplasms; Sepsis | 2016 |
Response to Re: Transrectal ultrasound-guided biopsy sepsis and the rise in carbapenem antibiotic use.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Biopsy; Biopsy, Needle; Carbapenems; Humans; Prostate; Prostatic Neoplasms; Sepsis | 2016 |
Carbapenem-resistant Leuconostoc Septicemia in an Immunocompetent Infant.
Topics: Anti-Bacterial Agents; Carbapenems; Humans; Immunocompromised Host; Infant; Leuconostoc; Sepsis | 2016 |
Use of Cepheid Xpert Carba-R® for Rapid Detection of Carbapenemase-Producing Bacteria in Abdominal Septic Patients Admitted to Intensive Care Unit.
Topics: Abdomen; Aged; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Humans; Intensive Care Units; Male; Middle Aged; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Sepsis | 2016 |
Does Thymoglobulin Induction Increase Susceptibility to Carbapenem-Resistant Acinetobacter baumannii Sepsis-related Death in Expanded Criteria Donors?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Antilymphocyte Serum; Brazil; Carbapenems; Delayed Graft Function; Disease Susceptibility; Donor Selection; Drug Resistance, Bacterial; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Odds Ratio; Pancreas Transplantation; Postoperative Complications; Retrospective Studies; Risk Factors; Sepsis; Tissue Donors | 2016 |
Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients with Sepsis.
Topics: Adult; Anti-Bacterial Agents; Carbapenems; Critical Illness; Doripenem; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Sepsis; Wounds and Injuries | 2016 |
Ethical consideration for use of carbapenems as treatment for sepsis due to carbapenem-resistant bacteria.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Resistance, Bacterial; Ethics, Medical; Humans; Sepsis | 2009 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
Prevalence and phenotypic characterisation of carbapenem resistance in Enterobacteriaceae bloodstream isolates in a tertiary care hospital in India.
Topics: beta-Lactam Resistance; beta-Lactamases; Blood; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Hospitals; Humans; India; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus mirabilis; Sepsis | 2011 |
Prevalence of antimicrobial resistant pathogens from blood cultures from Canadian hospitals: results of the CANWARD 2007-2009 study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Blood; Canada; Candida; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Resistance, Fungal; Emergency Service, Hospital; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Outpatient Clinics, Hospital; Patients' Rooms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Prevalence; Sepsis | 2011 |
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Sepsis | 2012 |
[Actual aspects of sepsis].
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Retrospective Studies; Russia; Sepsis; Vancomycin | 2011 |
First detection of blaIMI-2 gene in a clinical Escherichia coli strain.
Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sepsis; Sequence Analysis, DNA | 2012 |
Acinetobacter baumannii as a cause of sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sepsis | 2012 |
Complete genome sequence of the podoviral bacteriophage YMC/09/02/B1251 ABA BP, which causes the lysis of an OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolate from a septic patient.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriophages; Carbapenems; DNA Viruses; DNA, Circular; Drug Resistance, Bacterial; Genome, Viral; Humans; Molecular Sequence Data; Podoviridae; Sepsis; Sequence Analysis, DNA; Virus Diseases | 2012 |
Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.
Topics: Academic Medical Centers; Adult; Bacteremia; Carbapenems; Ceftazidime; Drug Resistance, Multiple; Febrile Neutropenia; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Penicillanic Acid; Piperacillin; Prevalence; Prospective Studies; Risk Factors; Sepsis; Singapore; Tazobactam; Treatment Outcome; Universities | 2012 |
Efficacy and safety of doripenem for sepsis with neutropenia in Japanese patients with hematologic diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Doripenem; Female; Humans; Liver; Male; Middle Aged; Neutropenia; Prospective Studies; Sepsis | 2012 |
[Carbapenems for septicemia. Seeking safe and effective treatment].
Topics: Carbapenems; Humans; Respiratory Tract Infections; Safety; Sepsis; Urinary Tract Infections | 2004 |
Rapid and quantitative detection of blood Serratia marcescens by a real-time PCR assay: its clinical application and evaluation in a mouse infection model.
Topics: Animals; Carbapenems; Disease Models, Animal; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Male; Mice; Mice, Inbred C57BL; Polymerase Chain Reaction; Sensitivity and Specificity; Sepsis; Serratia Infections; Serratia marcescens | 2005 |
Fatal multidrug-resistant Acinetobacter baumannii sepsis in a patient with travel history and recent onset of systemic lupus erythematosus: a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Female; Greece; Humans; Lupus Erythematosus, Systemic; Sepsis; Travel | 2006 |
[Losing no time in suspected sepsis. Every emergency bag should have a broad spectrum antibiotic! (interview by Dr. med. Horst Gross)].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Community-Acquired Infections; Cross Infection; Emergencies; Family Practice; Humans; Infusions, Intravenous; Penicillins; Sepsis | 2008 |
Therapeutic efficacy of BO-3482, a novel dithiocarbamate carbapenem, in mice infected with methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Dipeptidases; Imipenem; Kidney; Methicillin Resistance; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscle, Skeletal; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem.
Topics: Animals; Carbapenems; Cilastatin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Prodrugs; Protease Inhibitors; Sepsis | 1998 |
Carbapenem-induced endotoxin release in gram-negative bacterial sepsis rat models.
Topics: Animals; Bacterial Toxins; Carbapenems; Disease Models, Animal; Endotoxins; Enterobacteriaceae; Gram-Negative Bacteria; Pseudomonas aeruginosa; Rats; Rats, Wistar; Sepsis | 1998 |
Synergy and cumulated killing effect of the penems FCE 22101 and FCE 25199 in combination with gentamicin against bacteria isolated from septicaemia.
Topics: Animals; Bacteria; Carbapenems; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella; Microbial Sensitivity Tests; Rabbits; Sepsis; Staphylococcus aureus; Streptococcus sanguis | 1991 |
Comparative in-vitro activity of the penem FCE 22101 against recent European blood culture isolates.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Gram-Negative Bacteria; Humans; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas; Sepsis; Staphylococcus | 1989 |